Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity
出版年份 2017 全文链接
标题
Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 16, Issue 4, Pages 264-272
出版商
Springer Nature
发表日期
2017-01-06
DOI
10.1038/nrd.2016.233
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- T Cell Fate at the Single-Cell Level
- (2016) Veit R. Buchholz et al. Annual Review of Immunology
- Distinct Gene Regulatory Pathways for Human Innate versus Adaptive Lymphoid Cells
- (2016) Olivia I. Koues et al. CELL
- Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
- (2016) Romain Banchereau et al. CELL
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
- (2016) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity
- (2016) Stephan Halle et al. IMMUNITY
- Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
- (2016) Jonathan M. Pitt et al. IMMUNITY
- Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure
- (2016) Philippe Armand et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Imaging of Immunotherapy Targets in Cancer
- (2016) E. B. Ehlerding et al. JOURNAL OF NUCLEAR MEDICINE
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
- (2016) Tanguy Y Seiwert et al. LANCET ONCOLOGY
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- Functional characterization of somatic mutations in cancer using network-based inference of protein activity
- (2016) Mariano J Alvarez et al. NATURE GENETICS
- The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis
- (2016) Ido Amit et al. NATURE IMMUNOLOGY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The "cancer immunogram"
- (2016) C. U. Blank et al. SCIENCE
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Introducing a New Dimension to Molecular Disease Classifications
- (2016) Noémie Jourde-Chiche et al. TRENDS IN MOLECULAR MEDICINE
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- (2016) P.-L. Chen et al. Cancer Discovery
- Cross-Tissue Regulatory Gene Networks in Coronary Artery Disease
- (2016) Husain A. Talukdar et al. Cell Systems
- Biomarkers for the Clinical Use of PD-1/PD-L1 Inhibitors in Non–Small-Cell Lung Cancer
- (2016) Adrian G. Sacher et al. JAMA Oncology
- Innate Immune Recognition of Cancer
- (2015) Seng-Ryong Woo et al. Annual Review of Immunology
- How Do Cytotoxic Lymphocytes Kill Cancer Cells?
- (2015) L. Martinez-Lostao et al. CLINICAL CANCER RESEARCH
- Strategically Localized Dendritic Cells Promote Rapid T Cell Responses to Lymph-Borne Particulate Antigens
- (2015) Michael Y. Gerner et al. IMMUNITY
- Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
- (2015) Scott N. Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and Antitumor Activity of Anti–PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
- (2015) Junzo Hamanishi et al. JOURNAL OF CLINICAL ONCOLOGY
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- T cell metabolism drives immunity
- (2015) Michael D. Buck et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Financial Toxicity of Cancer Care: It’s Time to Intervene
- (2015) S. Yousuf Zafar JNCI-Journal of the National Cancer Institute
- Rapid Eradication of a Bulky Melanoma Mass with One Dose of Immunotherapy
- (2015) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
- (2015) Hossein Borghaei et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations
- (2015) W. Joost Lesterhuis et al. Scientific Reports
- Identifying early-warning signals of critical transitions with strong noise by dynamical network markers
- (2015) Rui Liu et al. Scientific Reports
- Financial Toxicity of Cancer Care: It’s Time to Intervene
- (2015) S. Yousuf Zafar JNCI-Journal of the National Cancer Institute
- Melanoma Brain Metastasis Pseudoprogression after Pembrolizumab Treatment
- (2015) J. V. Cohen et al. Cancer Immunology Research
- Regulated Cell Death: Signaling and Mechanisms
- (2014) Avi Ashkenazi et al. Annual Review of Cell and Developmental Biology
- CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
- (2014) Y. Zhu et al. CANCER RESEARCH
- Blood mRNA Expression Profiling Predicts Survival in Patients Treated with Tremelimumab
- (2014) Y. Saenger et al. CLINICAL CANCER RESEARCH
- Combination Therapy with Anti–CTLA-4 and Anti–PD-1 Leads to Distinct Immunologic Changes In Vivo
- (2014) Rituparna Das et al. JOURNAL OF IMMUNOLOGY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Comment on "Drug Discovery: Turning the Titanic"
- (2014) W. J. Lesterhuis et al. Science Translational Medicine
- The Relative Ineffectiveness of Criminal Network Disruption
- (2014) Paul A. C. Duijn et al. Scientific Reports
- Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab
- (2014) Saskia JAM Santegoets et al. Journal for ImmunoTherapy of Cancer
- Immune Modulation in Cancer with Antibodies
- (2013) David B. Page et al. Annual Review of Medicine
- Immunotherapy and the concept of a clinical cure
- (2013) Alexander M.M. Eggermont et al. EUROPEAN JOURNAL OF CANCER
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The diminishing role of hubs in dynamical processes on complex networks
- (2013) R. Quax et al. Journal of the Royal Society Interface
- Early Diagnosis of Complex Diseases by Molecular Biomarkers, Network Biomarkers, and Dynamical Network Biomarkers
- (2013) Rui Liu et al. MEDICINAL RESEARCH REVIEWS
- Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen
- (2013) Andrew L Doedens et al. NATURE IMMUNOLOGY
- Severe Sepsis and Septic Shock
- (2013) Derek C. Angus et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity
- (2013) W. Joost Lesterhuis et al. PLoS One
- Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
- (2013) Y. P. de Coana et al. Cancer Immunology Research
- Beyond differential expression: the quest for causal mutations and effector molecules
- (2012) Nicholas J Hudson et al. BMC GENOMICS
- T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment
- (2012) Saskia J. A. M. Santegoets et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation-Induced B Cell Fates Are Selected by Intracellular Stochastic Competition
- (2012) K. R. Duffy et al. SCIENCE
- Anticipating Critical Transitions
- (2012) M. Scheffer et al. SCIENCE
- Intracellular competition for fates in the immune system
- (2012) Ken R. Duffy et al. TRENDS IN CELL BIOLOGY
- An immune-active tumor microenvironment favors clinical response to ipilimumab
- (2011) Rui-Ru Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Interactome Networks and Human Disease
- (2011) Marc Vidal et al. CELL
- New Challenges in Endpoints for Drug Development in Advanced Melanoma
- (2011) A. Ribas et al. CLINICAL CANCER RESEARCH
- Interferon regulatory factor 7 is a major hub connecting interferon-mediated responses in virus-induced asthma exacerbations in vivo
- (2011) Anthony Bosco et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mathematical modelling of prostate cancer growth and its application to hormone therapy
- (2010) G. Tanaka et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES
- The Genetic Landscape of a Cell
- (2010) M. Costanzo et al. SCIENCE
- A Network Modeling Approach to Analysis of the Th2 Memory Responses Underlying Human Atopic Disease
- (2009) Anthony Bosco et al. JOURNAL OF IMMUNOLOGY
- The transcriptional network for mesenchymal transformation of brain tumours
- (2009) Maria Stella Carro et al. NATURE
- Early-warning signals for critical transitions
- (2009) Marten Scheffer et al. NATURE
- Dynamic modularity in protein interaction networks predicts breast cancer outcome
- (2009) Ian W Taylor et al. NATURE BIOTECHNOLOGY
- Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses
- (2009) I. Amit et al. SCIENCE
- Mistranslation of Membrane Proteins and Two-Component System Activation Trigger Antibiotic-Mediated Cell Death
- (2008) Michael A. Kohanski et al. CELL
- Nature, Nurture, or Chance: Stochastic Gene Expression and Its Consequences
- (2008) Arjun Raj et al. CELL
- Variability and Robustness in T Cell Activation from Regulated Heterogeneity in Protein Levels
- (2008) O. Feinerman et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now